BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36544784)

  • 1. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
    Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
    Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
    Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
    Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
    Zhai Y; Shen H; Wei H
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
    Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
    BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
    Tong X; Zhou F
    Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
    Hua J; Ding T; Shao Y
    Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
    Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
    Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
    Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
    Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
    Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
    Front Oncol; 2022; 12():966920. PubMed ID: 36276132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia.
    Huang K; Xie L; Wang F
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics.
    Wang N
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9609-9619. PubMed ID: 37222809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia.
    Dong L; Wang H; Miao Z; Yu Y; Gai D; Zhang G; Ge L; Shen X
    Hematology; 2023 Dec; 28(1):2246268. PubMed ID: 37589214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature.
    Jing L; Zhang B; Sun J; Feng J; Fu D
    Heliyon; 2024 Mar; 10(6):e28237. PubMed ID: 38532996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
    Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
    Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia.
    Jiang G; Jin P; Xiao X; Shen J; Li R; Zhang Y; Li X; Xue K; Li J
    Front Immunol; 2023; 14():1149513. PubMed ID: 37138885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.